Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Europe Pre-Open:Futures: FTSE (0.04%), DAX +0.10%, CAC40 +0.25%

Apr 30 ,2025

  • Synopsis

    • European equity markets are set to for a mixed to higher open. Note Sweden closes early for Labor Day with most European indices (except UK and Denmark) remaining shut tomorrow. Follows mostly positive close on Tuesday, which saw the Stoxx 600 record the sixth straight firmer close. FTSE 100 up for 12th session. US equity futures lower, with S&P down 0.5%.

    • In central banks, Estonia central bank's Muller speech/panellist at 8:35CET at bank hosted event on US tariff impact on economy. BOE's Truran speech at 9:30BST at the 22nd Conf. on bulk annuities and David Bailey speech at 10:15 at Climate Financial Risk Forum. ECB's Montagner in fireside chat at 11:15CET at Risk & Compliance Global Meeting organised by Boston Consulting. Bundesbank's Theurer panellist at 18:30CET at event hosted by VIGOnomics. Norges Bank releases its lending survey Q1 at 10:00CET. Estonia central bank seminar title The era of trade restrictions: how to adapt to the new reality?. In politics, France's President Macron hosts Chancellor Scholz in the evening to discuss bilateral relations as well as European and international policy issues. Norway's minister of energy Aasland speech at 12:30CET at the annual conf of Renewable Norway (Mon-Wed). In UK, weekly PMQs at 12noon BST, whilst committee topics include workforce planning to deliver clean, secure energy at 15:00. Economist hosts Greece's Transportation and Infrastructure Summit

    • A busy macro front sees Q1 preliminary GDP for Eurozone, Germany, France, Italy, Finland, Austria and Portugal. Also out are Germany, France, Italy and Portugal Apr preliminary CPI, Germany Mar retail sales and Apr unemployment change, France Mar consumer spending, PPI, Italy CPI, Mar PPI, Switzerland Apr leading indicators - KOF, economic sentiment index, Denmark Mar unemployment rate, Portugal Mar unemployment rate, Greece Feb retail sales, Mar unemployment rate, PPI, Ireland Apr preliminary HICP, unemployment rate.

    • On the earnings front, DACHs region companies kicked off the session with reports out from UBS Group (UBSG.SW), DHL Group (DHL.GR), Mercedes-Benz Group (MBG.GR), Volkswagen (VOW.GR), ams-OSRAM (AMS.SW), Hapag-Lloyd (HLAG.GR), OMV (OMV.AV), Siltronic (WAF.GR) and Logitech International (LOGN.SW). From the Benelux region, ArcelorMittal (MT.NA), Adyen (ADYEN.NA), Universal Music Group (UMG.NA) and ASM International (ASM.NA) released results. From France, Remy Cointreau (RCO.FP), Societe Generale (GLE.FP) and Valeo (FR.FP) updated investors. Elsewhere, Equinor (EQNR.NO), DSV (DSV.DC), Svenska Handelsbanken (SHB.A.SS), CaixaBank (CABK.SM) and Banco Santander (SAN.SM) reported Q1.

  • Politics/Macro/World News

    • Major companies withdrawing guidance due to tariff-related economic uncertainty

    • France Mar Consumer Spending (1.0%) m/m vs consensus +0.2% and prior revised (0.2%) from (0.1%)

    • Finland Q1 Preliminary GDP +1.2% y/y vs consensus +1.2% and prior +1.2%

  • Top company news

    • Earnings/updates

      • Benelux:

        • MT.NA (ArcelorMittal) -- reports Q1 EPS $1.05 vs consensus $0.66; caution about short-term outlook is appropriate

        • UMG.NA (Universal Music Group) -- reports Q1 adjusted EBITDA €661M vs StreetAccount €654.1M

        • ASM.NA (ASM International) -- reports Q1 adj net income €191.2M vs consensus €203.1M; guides Q2

        • AED.BB (Aedifica) -- reports Q1 EPRA NTA per share €77.86 vs year-ago €76.63

        • DSFIR.NA (DSM-Firmenich) -- reports Q1 revenue €3.27B vs consensus €3.28B

        • MELE.BB (Melexis) -- reports Q1 EPS €0.61 vs FactSet €0.59 [5 est, €0.52-0.71]; confirms its outlook

        • ONTEX.BB (Ontex Group) -- reports Q1 revenue €450.6M vs FactSet €543.9M [1 est]

        • APAM.NA (Aperam) -- reports Q1 EPS (€0.24) and unclear if comparable to FactSet €0.18 [2 est, €0.17-0.18]

        • ADYEN.NA (Adyen) -- reports Q1 revenue €534.7M vs FactSet €537.4M [5 est, €532-542M]; did not see any developments that would lead to update financial objectives

      • DACHs:

        • UBSG.SW (UBS Group) -- reports Q1 EPS $0.51 vs consensus $0.39

        • MBG.GR (Mercedes-Benz Group) -- reports Q1 EPS €1.74 vs StreetAccount €2.09; FY EBIT and free cash flow of industrial business, as well as adjusted returns on sales of Cars and Vans, will be negatively impacted if current trade policies persist

        • VOW.GR (Volkswagen) -- publishes Q1 final results; reports Q1 net income €2.19B, (41%) vs year-ago €3.68B

        • DHL.GR (DHL Group) -- reports Q1 EPS €0.67 vs consensus €0.65; changes in trade policy shaped Q1 and FY25 guidance unchanged

        • AMS.SW (ams-OSRAM) -- reports Q1 EPS (€0.23) ex-items vs FactSet (€0.19) [5 est, (€0.43)-0.05]; confirms FY outlook

        • LOGN.SW (Logitech International) -- reports Q4 EPS $0.93 ex-items vs StreetAccount $0.88

        • STMN.SW (Straumann Holding) -- reports Q1 revenue CHF680.7M vs StreetAccount CHF674.7M; confirms FY25 outlook

        • COP.GR (CompuGroup Medical) -- reports Q1 EPS €0.35 ex-items vs FactSet €0.41 [1 est]

        • AIXA.GR (Aixtron) -- reports Q1 EPS €0.04 vs consensus €0.05; FY25 guidance confirmed and will closely monitor impact of US tariff policie

        • SCHP.SW (Schindler Holding) -- reports Q1 EPS CHF2.26 vs StreetAccount CHF2.07

        • SDZ.SW (Sandoz Group) -- reports Q1 revenue $2.48B vs FactSet $2.59B [3 est, $2.54-2.65B]; confirms FY guidance

        • KGX.GR (Kion Group) -- reports Q1 EPS (€0.36) vs consensus (€0.36); reaffirms FY guidance

        • TKA.AV (Telekom Austria) -- reports Q1 net income €125M vs consensus €122M

        • COK.GR (CANCOM) -- reports preliminary Q1 EBITDA €21.1M vs year-ago €30.4M

        • HYQ.GR (Hypoport) -- reports preliminary Q1 EBIT ~€8.5M vs FactSet €7.1M [2 est, €6-8.2M]

        • IDIA.SW (Idorsia) -- reports Q1 net income CHF63M vs year-ago CHF30M; guides FY25

        • WCH.GR (Wacker Chemie) -- reports Q1 EPS (€0.16) vs consensus €0.02; Outlook for 2025 confirmed

        • NEM.GR (Nemetschek) -- reports Q1 EPS €0.45 vs FactSet €0.40 [7 est, €0.36-0.44]; confirms FY25 outlook

        • FPE3.GR (FUCHS SE) -- reports Q1 EPS €0.59 vs FactSet €0.63 [3 est, €0.60-0.66]

        • ACT.GR (AlzChem Group) -- reports Q1 EPS €1.44 vs year-ago €1.20

        • WAF.GR (Siltronic) -- reports Q1 EPS €0.08 vs FactSet (€0.32) [6 est, (€0.81)-0.02]

        • OMV.AV (OMV) -- reports Q1 Clean CCS Net Income attributable €413M vs consensus €486M

        • EBS.AV (Erste Group Bank) -- reports Q1 net income €743M vs consensus €748.5M

        • HLAG.GR (Hapag-Lloyd) -- reports prelim Q1 EBIT €500M vs FactSet €569.5M [1 est]; FY forecast confirmed subject to considerable uncertainty due to volatile development of freight rates and major geopolitical challenges

      • France:

        • GLE.FP (Societe Generale) -- reports Q1 net income €1.61B vs consensus €1.21B

        • FR.FP (Valeo SE) -- reports Q1 revenue €5.31B vs consensus €5.31B; taking necessary steps to improve its profitability and cash generation

        • RCO.FP (Remy Cointreau) -- reports prelim Q4 sales €196.8M vs consensus €197M; outlook confirmed

        • ABVX.FP (Abivax) -- completes enrollment for the Phase 3 ABTECT trials in patients with moderately to severely active ulcerative colitis

        • NEX.FP (Nexans) -- reports Q1 sales at constant metal prices €1.82B vs FactSet €1.88B [3 est, €1.59-2.26B]

        • ACA.FP (Credit Agricole) -- reports Q1 EPS €0.56 vs FactSet €0.59 [6 est, €0.51-0.67]

        • CO.FP (Casino Guichard-Perrachon) -- reports Q1 adjusted EBITDA €100M, (6%) vs year-ago €106M

        • VIRI.FP (Viridien) -- reports Q1 adj EBITDA $143M vs year-ago $106M; comments on FY25 outlook

        • BOL.FP (Bolloré) -- reports Q1 revenue €782M, +4% vs year-ago €751M

        • VANTI.FP (Vantiva) -- reports Q1 revenue €406M, +13% vs year-ago €358M

        • VCT.FP (Vicat) -- reports Q1 revenue €886M, (3%) vs year-ago €911M

        • LOCAL.FP (Solocal Group) -- reports H1 revenue €82.9M vs year-ago €83.3M

        • VLTSA.FP (Voltalia) -- reports Q1 revenue €113.3M, +2% vs year-ago €111.1M

        • ICEAIR.IR (Icelandair Group) -- reports Q1 net income ($44.1M) vs year-ago ($59.4M); FY guidance not be reaffirmed at this time

        • PIG.FP (Haulotte Group) -- reports Q1 revenue €131M, (17%) vs year-ago €157M

        • CNV.FP (Cnova) -- reports Q1 EBITDA €10.8M vs year-ago €13.6M

        • S30.FP (Solutions 30) -- reports Q1 revenue €232.4M, (12%) vs year-ago €265.0M

        • ALTHX.FP (Theranexus) -- reports FY net income (€1.8M) vs year-ago (€6.8M)

        • ALCOX.FP (Nicox) -- reports FY net income (€22.4M) vs FactSet (€14.5M) [1 est]

        • TE.FP (Technip Energies) -- reports Q1 EPS €0.56 vs FactSet €0.57 [5 est, €0.52-0.60]

      • Nordics:

        • EQNR.NO (Equinor) -- reports Q1 adjusted net income $1.79B vs consensus $2.38B; proposed second tranche buyback of up to $1.265B

        • SHB.A.SS (Svenska Handelsbanken) -- reports Q1 EPS SEK3.19 vs FactSet SEK2.97 [13 est, SEK2.78-3.10]

        • KNEBV.FH (Kone) -- reports Q1 EPS €0.41 vs consensus €0.42

        • BGBIO.NO (BerGenBio) -- decides to only publish half yearly financial reports; cites previously disclosed ongoing strategic review and the cost savings initiative

        • EVO.SS (Evolution) -- reports Q1 EPS €1.24 vs FactSet €1.35 [8 est, €1.30-1.39]

        • AKBM.NO (Aker BioMarine) -- reports Q1 net income (cont ops) ($2.0M) vs FactSet ($0.9M) [2 est, ($2)-0.2M]

        • ZAL.NO (Zalaris) -- reports Q1 EPS NOK1.37 vs year-ago NOK0.26

        • PIHLIS.FH (Pihlajalinna) -- reports Q1 EPS €0.47 vs FactSet €0.43 [5 est, €0.41-0.45]

        • PARB.NO (Pareto Bank) -- reports Q1 EPS NOK2.16 vs year-ago NOK2.15

        • BRG.NO (Borregaard) -- reports Q1 EPS NOK2.52 vs FactSet NOK2.18 [6 est, NOK1.90-2.40]

        • NEL.NO (NEL ASA) -- reports Q1 EPS (NOK0.10) vs FactSet (NOK0.06) [6 est, (NOK0.10)-0.00]

        • EGTX.SS (Egetis Therapeutics) -- reports Q1 EPS (SEK0.2) vs FactSet (SEK0.24) [2 est, (SEK0.24)-(0.23)]

        • MORG.NO (Sparebanken Møre) -- reports Q1 EPS NOK2.13 vs FactSet NOK2.36 [4 est, NOK2.30-2.43]

        • ELK.NO (Elkem) -- reports Q1 EPS (NOK0.33) vs FactSet NOK0.40 [2 est, NOK0.10-0.70]; comments on Q2

        • AKAST.NO (Akastor) -- reports Q1 net income (NOK197M) vs year-ago NOK593M

        • HELN.SW (Helvetia Holding) -- reports SST ratio of 288% as of 31-Dec-24

        • AKSO.NO (Aker Solutions) -- reports Q1 EPS NOK1.35 vs FactSet NOK1.37 [6 est, NOK0.90-1.66

        • RILBA.DC (Ringkjøbing Landbobank) -- reports Q1 net income DKK616M vs FactSet DKK555.8M [4 est, DKK544-567M]

        • DSV.DC (DSV) -- reports Q1 net income DKK2.87B ex-items vs consensus DKK2.59B

      • Southern Europe:

        • SAN.SM (Banco Santander) -- reports Q1 underlying attributable profit €3.40B vs consensus €3.13B; on track to meet its 2025 targets

        • CABK.SM (CaixaBank) -- reports Q1 net income €1.47B vs consensus €1.29B

        • PRS.SM (Promotora de Informaciones) -- reports Q1 net income (€4M) vs FactSet (€4.7M) [2 est, (€8)-(1.4M)]

        • ENC.SM (ENCE Energia y Celulosa) -- reports Q1 net income €2.4M vs FactSet €2.2M [3 est, (€0.7)-6M]

      • UK/Ireland:

        • PRU.LN (Prudential) -- Q1 update: APE sales +4% y/y to $1.68B

        • A5G.ID (AIB Group) -- reports Q1 EPS €0.22 vs year-ago €0.17

    • M&A

      • SESG.FP (SES) -- EU sets a provisional deadline of 10-Jun to rule on SES' acquisition of Intelsat

      • SNR.LN (Senior) -- Sullivan Street Partners nearing deal to acquire Senior's aerostructures unit - Bloomberg

      • DAL.IM (Datalogic) -- acquires Datema Retail Solutions AB for an initial ~€3M (11:18ET)

      • EWIND.NO (Edda Wind) -- Electric AS raises stake in Edda Wind

      • HB.CY (Hellenic Bank Public Co.) -- Eurobank now holds 97.994% of Hellenic Bank; to exercise squeeze out right at €4.843/sh

      • NY Mets TV broadcaster SportsNet New York said to be exploring options including potential sale -- wires

    • Healthcare

      • ADXN.SW (Addex Therapeutics) -- enters option- and collaboration agreement with Sinntaxis AB for an exclusive license to intellectual property covering the use of metabotropic glutamate receptor subtype 5 inhibitors for the treatment of brain injury recovery

      • SAN.FP (Sanofi) -- FDA grants orphan drug designation to riliprubart for AMR

      • ROG.SW (Roche Holding) -- Roche announces CHMP recommends EU label update for Roche's Phesgo to allow administration outside of clinical settings

      • IPH.FP (Innate Pharma) -- highlights preclinical anti-tumor efficacy data of its antibody drug conjugate IPH4502 at AACR 2025

    • Other

      • RILBA.DC (Ringkjøbing Landbobank) -- launches new DKK 1.00B buyback; expected to commence end of May 2025

      • AMSC.NO (AMSC) -- under liquidation; CFO Morten Bakke to step down

      • HBH.GR (Hornbach) -- appoints Joanna Kowalska as CFO effective 15-Aug

      • NESN.SW (Nestle) -- launches new joint cocoa agroforestry partnership with ingredient supplier ofi

      • BRBY.LN (Burberry Group) -- launches formal search for new chairman to succeed Gerry Murphy - Sky News

      • SUBC.NO (Subsea 7) -- and SLB OneSubsea awarded EPCI contract for bp's Ginger project

      • White House confirms plans to soften automotive tariff impact - CNBC

      • White House publishes Executive Order outlining revisions to auto tariffs/relief from "stacked" tariffs, as expected

  • Key rating changes

    • Upgrades

      • THULE.SS (Thule Group) -- buy from hold at Kepler Cheuvreux

      • TIETO.FH (Tietoevry) -- hold from sell at Handelsbanken

      • SOBI.SS (Swedish Orphan Biovitrum) -- buy from hold at Kepler Cheuvreux

      • SWEC.B.SS (Sweco) -- buy from hold at Carnegie Securities

      • DATA.LN (GlobalData) -- buy from hold at Deutsche Numis

    • Downgrades

      • GJF.NO (Gjensidige Forsikring) -- hold from buy at ABG Sundal Collie

      • ZAL.GR (Zalando) -- underweight from equal-weight at Morgan Stanley

      • PSM.GR (ProSiebenSat.1 Media) -- to equal weight from overweight at Barclays

      • EPI.A.SS (Epiroc) -- to hold from buy at Pareto (earlier, timing uncertain)

      • INW.IM (Infrastrutture Wireless Italiane) -- to equal weight from overweight at Barclays

      • FUR.NA (Fugro) -- to neutral from outperform at BNP Paribas Exane

      • THG.LN (THG Plc) -- to hold from buy at HSBC

      • ARJO.B.SS (Arjo) -- to sell from hold at Danske Bank

    • Initiations

      • ELG.GR (Elmos Semiconductor) -- buy at Berenberg

      • GFRD.LN (Galliford Try Holdings) -- buy at Berenberg

    • Other Actions

      • XXL.NO (XXL ASA) -- reinstated hold at DnB Markets

  • Data

    • Nikkei +0.36% to 35968.83

    • Hang Seng +0.23% to 22057.72

    • Shanghai Composite (0.13%) to 3282.37

    • S&P futures (23.8) vs prior close of 5583.8

    • €-$ (0.0003) or (0.03%) to 1.1384

    • $-¥ +0.17 or +0.12% to 142.53

    • €-¥ +0.08 or +0.05% to 162.1

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE